EP0453555A1 - Vorratsbehälter für einen bestandteil einer medikamentenlösung. - Google Patents

Vorratsbehälter für einen bestandteil einer medikamentenlösung.

Info

Publication number
EP0453555A1
EP0453555A1 EP91900240A EP91900240A EP0453555A1 EP 0453555 A1 EP0453555 A1 EP 0453555A1 EP 91900240 A EP91900240 A EP 91900240A EP 91900240 A EP91900240 A EP 91900240A EP 0453555 A1 EP0453555 A1 EP 0453555A1
Authority
EP
European Patent Office
Prior art keywords
bottle
neck
capsule
bottle according
closure member
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP91900240A
Other languages
English (en)
French (fr)
Other versions
EP0453555B1 (de
Inventor
Gabriel Meyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson France SA
Original Assignee
Medicorp Holding SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicorp Holding SA filed Critical Medicorp Holding SA
Publication of EP0453555A1 publication Critical patent/EP0453555A1/de
Application granted granted Critical
Publication of EP0453555B1 publication Critical patent/EP0453555B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2089—Containers or vials which are to be joined to each other in order to mix their contents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1475—Inlet or outlet ports
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006—Piercing means
    • A61J1/201—Piercing means having one piercing end
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202—Separating means
    • A61J1/2031—Separating means having openings brought into alignment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202—Separating means
    • A61J1/2041—Separating means having removable plugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2068—Venting means
    • A61J1/2072—Venting means for internal venting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2096—Combination of a vial and a syringe for transferring or mixing their contents

Definitions

  • the present invention relates to a storage bottle containing a component of a medicinal substance and a transfer device for transferring this substance directly, or after having mixed it with another substance, in an end-use container, this bottle comprising an open narrowed neck and the transfer device comprising a closure member at least partially engaged in this neck, at least during storage.
  • the medicinal substances are usually stored in containers which can be either glass vials sealed with flame, or bottles closed by a stopper shutter.
  • containers which can be either glass vials sealed with flame, or bottles closed by a stopper shutter.
  • this liquid must be introduced into the storage bottle to come into contact with the solid or pulvé ⁇ rulent component and to dissolve it.
  • the closure member must be pierced to allow the liquid to flow or pushed entirely inside the bottle so as to release the neck, or else partially pushed back so as to release a lateral opening allowing the passage of the liquid.
  • a first problem posed by known bottles is that occa ⁇ sioned by the piercing of the closure member to allow to transfer the solvent inside the bottle.
  • This piercing can tear elastomeric material from the plug usually used as a sealing member, and the torn particles can, in some cases, be injected into the body and cause serious disorders.
  • the present invention overcomes the disadvantages of known prior systems and eliminates all the risks associated with piercing a shutter member.
  • a second problem posed by known bottles is that of the waterproof barrier and the aseptic barrier.
  • the closure member must fulfill several functions and must meet several requirements both during storage and during use.
  • the obturation member During the use phase, it must constitute both a tight barrier and an aseptic barrier preventing in particular any bacterial penetration inside the bottle.
  • the obturation member During the use phase, the obturation member must maintain, in particular in the initial activation phase, an aseptic barrier to protect the contents of the vial and free access to the interior of this vial to allow - solvent penetration.
  • the present invention is designed to solve this problem by structuring the shutter member so that it can fulfill all of the functions defined above.
  • a third problem posed by known bottles is due to the fact that during the dissolution of the component by the solvent, large amounts of gas and in particular carbon dioxide can be released, which generates a significant overpressure in the bottle or in the container. of use.
  • this gas can be transferred into this container.
  • this gas must imperatively be evacuated, at least in part.
  • the present invention also makes it possible to solve this problem by providing means for evacuating the pressurized gas inside the storage bottle when the pulverulent solid substance is dissolved by the solvent.
  • the bottle is characterized in that the closure member consists of two elements: a first element consisting of a solid elastomer stopper whose diameter is substantially equal to that of the neck of the bottle and which is engaged in this neck for sealing it during storage, and a second element constituted by an elastomer O-ring whose outside diameter is substantially equal to that of the neck of the bottle and which is engaged in this neck and in that the transfer device also comprises at least one interior opening which opens into the space provided between said first element and said second element.
  • a first element consisting of a solid elastomer stopper whose diameter is substantially equal to that of the neck of the bottle and which is engaged in this neck for sealing it during storage
  • a second element constituted by an elastomer O-ring whose outside diameter is substantially equal to that of the neck of the bottle and which is engaged in this neck and in that the transfer device also comprises at least one interior opening which opens into the space provided between said first element and said second element.
  • the transfer device comprises a capsule adapted over the neck of the bottle, movable between a storage position in which it is partially engaged on the neck and an activated position in which it is completely engaged on this neck, and the capsule is integral with the closure member.
  • said first element of the closure member is independent and designed to detach and fall inside the bottle during the use phase.
  • said first element of the shutter member can be coupled to the capsule.
  • said first element is a lyophilization stopper comprising a solid upper part and a lower extension provided with lateral vents, this extension being designed to ensure prepositioning of the stopper on the neck of the bottle during the lyophilization of the substance. contained in this bottle.
  • the capsule has a substantially cylindrical inner part comprising at least one shoulder serving to support said second element of the closure member and provided with at least one opening opening into the defined space. by the two elements and by the inner surface of the neck in the storage position of this bottle.
  • Said internal opening opening into the space formed between said first and second elements can be formed in the wall of the central part of the capsule and making said space communicate with a central cavity of this capsule.
  • the transfer device is provided with at least one vent also opening into the space provided between said first element and said second element of the shutter member.
  • Said vent may include a calibrated orifice and be associated with a filter.
  • said filter is of the hydrophobic type.
  • said vent can be constituted by a second duct of a double-duct trocar, the openings of this second duct being offset with respect to those of said first duct.
  • Said vent can also be made in the bottom of the central part of the capsule and lead into the central cavity of this capsule.
  • fig. 1, 2, and 3 illustrate a first embodiment of the bottle according to the invention containing a powdery substance, successive ⁇ sively during the storage phase, the transfer phase of a solvent and the transfer phase of the final drug solution
  • fig. represents a storage bottle according to the invention containing a lyophilisate, and provided with an appropriate closure cap,
  • fig. 5 shows the storage bottle of FIG. 4, containing a powder and provided with a suitable closure cap
  • fig. 6 shows a perspective view of the closure cap of the storage bottle of FIG. 4,
  • fig. 7 shows a perspective view of the closure cap of the storage bottle of FIG. 5,
  • fig. 8 shows a sectional view of an embodiment of the closure member of a storage bottle according to the invention
  • fig. 9 shows a sectional view of another form of embodiment of the closure member of a storage bottle according to the invention.
  • fig. 10 shows a sectional view of a storage bottle according to the invention in the context of a particular use
  • fig. 11 shows a sectional view of a storage bottle according to the invention in the context of another use
  • fig. 12 shows a sectional view of a storage bottle according to the invention in the context of a third use
  • fig. 13 shows a sectional view of a storage bottle according to the invention, equipped with a different transfer device
  • fig. 14 and 15 represent two views of storage vials associated with two separate syringes
  • fig. 16 shows a sectional view schematically illustrating another transfer device adapted to a storage bottle according to the invention.
  • the storage bottle 10 is associated with a transfer device 11 which is adapted on the neck 12 of the bottle 10 containing a medicinal substance 13 in the powder state.
  • the neck 12 of the bottle 10 is substantially cylindrical and of reduced section compared to that of the body.
  • the transfer device 11 consists in this case of an elongated element 14 in the form of a trocar consisting of a double needle and of a closure member 15.
  • This closure member comprises a first element constituted by a solid plug made of elastomer 16a which is engaged in the neck and at a diameter slightly greater than the latter, and a second element 16b also engaged in the neck and which is constituted by an O-ring made of elastomer.
  • This device is protected by a cap 17 which covers the entire device and the free lower edge 18 of which bears against a shoulder 19 which provides the connection between the neck and the body of the bottle 10.
  • the elongated element 14 has two conduits axial, respectively 20 and 21, each provided with a first opening 20a, respectively 21a, designed to open inside the bottle, and a second opening 20b, respectively 21b, opening outside the bottle.
  • the elongate element 14 ends with a point 22 at its end external to the bottle. It will be noted that the orifices opening out inside the bottle, that is to say the orifices 20a and 21a, are offset axially with respect to each other and that the orifices 20b and 21b opening out are also axially offset from each other.
  • a capsule 23 integral with the closure member 15 is engaged over the neck 12 of the bottle and serves as a seat for the cap 17.
  • this capsule is integral with the elongated element 14. Furthermore, it serves as a support for the second element 16b of the shutter member 15.
  • Said full stopper 16a constitutes a tight barrier for closing the bottle during the storage phase.
  • the capsule 23 has an inner part 24, of substantially cylindrical and concave shape, arranged to be able to slide inside the neck 12 of the bottle, and an outer part 25 which passes over the rim 26 of this neck 12, in particular at when the device is brought from the storage position to the active position.
  • FIG. 2 This phase is represented in particular by FIG. 2.
  • the protective cap 17 has been removed and the elongated element has been inserted inside a container 30 containing a liquid 31 intended to dissolve the powder 13 contained in the bottle 10.
  • the element elongated was used to pierce the closure cap 32 of the container 30.
  • the capsule 23 was pressed on the neck 12 of the bottle 10, which had the effect of pushing the first element 16a of the organ of obturation 15 inside this bottle and to release the orifices 20a and 21a.
  • the liquid 31, contained in the container 30, flows through the axial duct 20 inside the bottle 10, and the air, initially contained in the bottle 10, or the gases generated by the reaction of the solvent 31 on the powder 13, are discharged through the axial channel 21 in the container 30.
  • the powder is a substance which reacts with the solvent by releasing a large amount of gas
  • the container is made of glass or of a material which withstands high overpressure.
  • the liquid 31 dissolves the powdery substance 13 and constitutes a solution liquid medicament which can then be transferred almost integrally into the container 30, after inversion of the assembly as shown in FIG. 3.
  • the transfer device makes it possible to connect two rigid bottles and that the transfer operation proper can be carried out in a sterile environment with a minimum risk of contamination.
  • the device makes it possible to transfer in two directions, that is to say from one bottle to another or vice versa, of any liquid substance.
  • the activation of the device is done in a simple way by sliding the transfer device associated with one of the bottles. The process can be stopped at any time.
  • Figs. 4 and 5 illustrate two storage flasks which differ essentially in that the first is intended to contain a lyophilisate 40 and the second a powder 41.
  • This difference in desti ⁇ nation leads to a difference in construction: the first vial includes a member for obturation 15, the first element 16a of which is a lyophilization plug as shown in perspective in FIG. 6, and the second bottle comprises a closure member 15, the first element 16a of which is a simple stopper as shown in perspective in FIG. 7.
  • the transfer device 11 consists of a needle 42 and the shutter member 15. 11 is, as for the previous embodiment, protected by a cap 17. During storage, this cap 17 is linked to the bottle 10 by a tamper-evident label 43.
  • the closure member 15 consists of said first element 16a defined above and the second element 16b which is again an elastomer O-ring located between the internal surface of the neck 12 of the bottle and the internal part 24 of the capsule 23
  • This inner part has a central cavity 44 and is equipped, in the area between the first element 16a and the second element 16b of the shutter member 15, with large openings 45.
  • the inner part 24 of the capsule 23 is coupled to said first element 16a of the closure member. This is to prevent this element from falling inside the bottle when the latter is activated.
  • the bottom 46 of the capsule is provided with vents 47 whose role will be explained below.
  • a filter 48 is fixed inside the bottom 6 and constitutes the compulsory passage between the inside of the bottle and the central channel of the needle 42.
  • This needle is integral with a needle-holder tip 49 and is fixed on a cone 50 secured to the bottom 46 of the capsule.
  • the needle 42 is protected by a tubular element 51 which is engaged by its annular base 52 of bent section, on the end of the capsule 23.
  • the operator After having pricked the needle 42 in a vial or a pocket containing a liquid solvent (not shown), pushes the capsule back to engage it fully in the neck of the vial.
  • the first element 16a of the closure member 15 penetrates entirely inside the bottle without however falling into this bottle since it is retained by the end of the inner part 24 of the capsule 23.
  • the liquid crosses the channel central of the needle, the central cavity of the capsule, the openings 45 and enters the vial.
  • the dissolution of the lyophilisate 40 or of the powder 41 can, in certain cases, lead to a strong evolution of gas, in particular carbon dioxide, which can escape through the large openings 45 and the vents 47 without disturbing the flow of the liquid or cause excessive pressure in the bottle.
  • the element 16a represented by FIG. 6 has a solid upper part 60 and a mouthpiece 61 which has a cross section in the form of a cross providing lateral vents 62 which allow the evacuation of gases when the element 16a is prepositioned on the neck of the bottle during the operation lyophilization.
  • the element 16a illustrated by FIG. 7 corresponds to the solid upper part of the element shown in fig. 6. When the bottle is filled with powder, the pre-positioning tip required for freeze-drying can be removed.
  • Figs. 8 and 9 illustrate two embodiments, sectional views of the closure member of the bottle according to the invention.
  • Fig. 8 represents a shutter member identical in all points to that described above with reference to FIG. 5. However, the shutter member of FIG. 5 is shown in the storage position while that of FIG. 8 is shown in the activated position.
  • the first element 16a of the closure member is connected to the lower end of the interior part 24 of the capsule 23, which prevents this element from falling inside the bottle.
  • the bottom of the central cavity 44 of the capsule is closed by a filter 48.
  • a recess 70 formed at the bottom of this central cavity communicates by a conduit 71 with an annular groove 72 to constitute said vents whose role has been described above.
  • the embodiment shown in FIG. 9 differs somewhat in that the vents 47 are designed differently.
  • the central cavity 44 communicates through channels 80 with an annular groove 81 which is separated from an annular groove 82 by an annular filter 83 which has the property of being hydrophobic.
  • the groove 82 communicates with the outside via a channel 84 which has a calibrated diameter. The diameter of this channel is determined in such a way that the overpressure generated for example by the generation of gas at the time of the dissolution of the powder by the solvent, can be released slowly.
  • Channel 84 defines a calibrated leak.
  • Fig. 10 illustrates another use of the bottle according to the invention.
  • the bottle 10, the closure member 15 and the capsule 23 are identical in all respects to those described above.
  • the capsule is adapted to receive a needle 90 intended to pierce a stopper 91 of a flexible bottle 92 containing a liquid solvent.
  • Needle 90 is advantageously made of synthetic material and comprises a central channel 93 and a lateral opening 94 through which the liquid intended to dissolve the powdery medicinal substance or in the state of lyophilisate initially contained in the bottle can flow.
  • the capsule 23 is provided with vents 47 allowing the evacuation of the overpressure gases contained in the bottle.
  • Fig. 11 illustrates another use of the bottle according to the invention.
  • This bottle is identical in all respects to that shown in FIG. 5.
  • the needle 42 has been inserted into the closure cap 100 of a flexible infusion bag 101 equipped with an infusor 102.
  • This infusion bag contains the solvent which is intended to be introduced into the bottle 10 to dissolve the powder or lyophilisate it contains before the solution is poured back into the infusion bag.
  • Fig. 12 illustrates a form of use of the bottle in which the capsule 23 is arranged to allow the coupling by screwing of an end piece 103 of a bottle 104 containing a liquid solvent.
  • This end fitting contains a shutter 105 which provides an axial conduit 106 for the passage of the liquid in the enlarged area 107 of the neck 108 of the bottle 104.
  • the first element 16a of the closure member 15 is fixed to the end of the capsule 23 which has at least one opening 45 allowing the passage of the liquid.
  • Fig. 13 illustrates another embodiment in which the capsule 23 is equipped with a tip 110 of the Luer-Lock type.
  • Figs. 14 and 15 illustrate two uses of the bottle according to the invention when the latter is connected to syringes.
  • a pre-filled syringe 120 of a type known per se, is coupled to a bottle, the capsule of which is provided with a tip of the Luer-Lock type as shown in FIG. 13.
  • a traditional syringe 130 is coupled to a connection nozzle 131 provided with a Luer cone, integral with the capsule 23.
  • the bottle illustrated in fig. 16 comprises a capsule, the part of which faces the interior of the bottle 10 is extended by a stud 140 which serves as a pusher for pushing said first element 16a from the closure member 15, when the bottle is brought from the storage position. in the activation position.
  • said first element 16a of the shutter member 15 is not linked to the capsule as was the case in most of the previous embodiments.
  • the second element 16b of the shutter member performs a dual function. During storage, this element acts as a protective barrier against bacteria and prevents contamination of the substance stored inside the bottle. During use, this second element constitutes a seal which prevents an undesirable flow of the drug solution between the capsule and the interior wall of the neck of the bottle.
EP19910900240 1989-11-13 1990-11-10 Vorratsbehälter für einen bestandteil einer medikamentenlösung Expired - Lifetime EP0453555B1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH408189 1989-11-13
CH4081/89 1989-11-13

Publications (2)

Publication Number Publication Date
EP0453555A1 true EP0453555A1 (de) 1991-10-30
EP0453555B1 EP0453555B1 (de) 1993-10-06

Family

ID=4269470

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19910900240 Expired - Lifetime EP0453555B1 (de) 1989-11-13 1990-11-10 Vorratsbehälter für einen bestandteil einer medikamentenlösung

Country Status (9)

Country Link
US (1) US5358501A (de)
EP (1) EP0453555B1 (de)
JP (1) JPH0659302B2 (de)
AT (1) ATE95415T1 (de)
CA (1) CA2045408A1 (de)
DE (1) DE69003805T2 (de)
DK (1) DK0453555T3 (de)
ES (1) ES2046039T3 (de)
WO (1) WO1991007160A1 (de)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5613291A (en) * 1995-01-25 1997-03-25 Becton, Dickinson And Company Method for providing a sterility seal in a medicinal storage bottle
US5653694A (en) * 1995-04-13 1997-08-05 Advanced Cytometrix, Inc. Aspiration needle apparatus incorporating its own vacuum and method and adapter for use therewith
US5902280A (en) * 1995-04-13 1999-05-11 Advanced Cytometrix, Inc. Aspiration needle apparatus incorporating its own vacuum and method and adapter for use therewith
US5746724A (en) * 1995-04-13 1998-05-05 Advanced Cytometrix, Inc. Aspiration needle apparatus incorporating its own vacuum and method and adapter for use therewith
JP2000515771A (ja) * 1995-04-13 2000-11-28 アドヴァンスド サイトメトリックス インコーポレイテッド 真空圧自蔵吸引針装置、方法およびこれと共に使用するアダプタ
US5685845A (en) * 1995-07-11 1997-11-11 Becton, Dickinson And Company Sterile resealable vial connector assembly
CA2185494A1 (en) 1995-09-27 1997-03-28 Jean-Pierre Grimard Resealable vial with connector assembly having a membrane and pusher
US5702019A (en) * 1995-09-27 1997-12-30 Becton Dickinson France S.A. Vial having resealable membrane assembly activated by a medical delivery device
US6003702A (en) * 1995-09-27 1999-12-21 Becton Dickinson France, S.A. Vial with resealable connector assembly having a membrane and a multi-configuration fluid access device
EP0895466A1 (de) 1996-04-22 1999-02-10 Abbott Laboratories Behälterverschlusssystem
US5871110A (en) * 1996-09-13 1999-02-16 Grimard; Jean-Pierre Transfer assembly for a medicament container having a splashless valve
CA2211629A1 (en) * 1996-09-17 1998-03-17 Bernard Sams Vial connector assembly for a medicament container
US5785701A (en) * 1996-09-17 1998-07-28 Becton Dickinson And Company Sterile vial connector assembly for efficient transfer of liquid
US5873872A (en) * 1996-09-17 1999-02-23 Becton Dickinson And Company Multipositional resealable vial connector assembly for efficient transfer of liquid
US5819964A (en) * 1996-09-27 1998-10-13 Becton Dickinson And Company Lyophilization closure assembly for a medicament container for use during a lyophilization process
US6036680A (en) * 1997-01-27 2000-03-14 Baxter International Inc. Self-priming solution lines and a method and system for using same
US5891129A (en) 1997-02-28 1999-04-06 Abbott Laboratories Container cap assembly having an enclosed penetrator
US5924584A (en) * 1997-02-28 1999-07-20 Abbott Laboratories Container closure with a frangible seal and a connector for a fluid transfer device
MY125870A (en) 1997-07-25 2006-08-30 Alza Corp Osmotic delivery system flow modulator apparatus and method
JPH11104215A (ja) * 1997-08-12 1999-04-20 Becton Dickinson Fr Sa ガラス瓶コネクタアセンブリ
US6090093A (en) * 1997-09-25 2000-07-18 Becton Dickinson And Company Connector assembly for a vial having a flexible collar
US6213994B1 (en) 1997-09-25 2001-04-10 Becton Dickinson France, S.A. Method and apparatus for fixing a connector assembly onto a vial
US5925029A (en) * 1997-09-25 1999-07-20 Becton, Dickinson And Company Method and apparatus for fixing a connector assembly onto a vial with a crimp cap
EP0904763B1 (de) 1997-09-25 2005-12-14 Becton Dickinson France S.A. Verbinder mit Verriegelungsring für eine Phiole
US6019750A (en) 1997-12-04 2000-02-01 Baxter International Inc. Sliding reconstitution device with seal
US6382442B1 (en) 1998-04-20 2002-05-07 Becton Dickinson And Company Plastic closure for vials and other medical containers
US6681946B1 (en) 1998-02-26 2004-01-27 Becton, Dickinson And Company Resealable medical transfer set
US6003566A (en) * 1998-02-26 1999-12-21 Becton Dickinson And Company Vial transferset and method
US6209738B1 (en) 1998-04-20 2001-04-03 Becton, Dickinson And Company Transfer set for vials and medical containers
US6904662B2 (en) 1998-04-20 2005-06-14 Becton, Dickinson And Company Method of sealing a cartridge or other medical container with a plastic closure
US6957745B2 (en) 1998-04-20 2005-10-25 Becton, Dickinson And Company Transfer set
US6378714B1 (en) 1998-04-20 2002-04-30 Becton Dickinson And Company Transferset for vials and other medical containers
US20050137566A1 (en) 2003-12-23 2005-06-23 Fowles Thomas A. Sliding reconstitution device for a diluent container
US6022339A (en) 1998-09-15 2000-02-08 Baxter International Inc. Sliding reconstitution device for a diluent container
AR021220A1 (es) 1998-09-15 2002-07-03 Baxter Int DISPOSITIVO DE CONEXIoN PARA ESTABLECER UNA COMUNICACIoN FLUíDA ENTRE UN PRIMER RECIPIENTE Y UN SEGUNDO RECIPIENTE.
US6234196B1 (en) * 1999-02-19 2001-05-22 Ultradent Products, Inc. Mixing adaptor and system
EP1328256B1 (de) 1999-12-21 2005-10-19 Alza Corporation Ventil für osmotische vorrichtungen
US7799009B2 (en) * 2000-01-24 2010-09-21 Bracco Diagnostics Inc. Tabletop drug dispensing vial access adapter
US6503240B1 (en) 2000-01-24 2003-01-07 Brocco Diagnostics, Inc. Vial access adapter
US6832994B2 (en) 2000-01-24 2004-12-21 Bracco Diagnostics Inc. Table top drug dispensing vial access adapter
US6139534A (en) * 2000-01-24 2000-10-31 Bracco Diagnostics, Inc. Vial access adapter
US6544246B1 (en) 2000-01-24 2003-04-08 Bracco Diagnostics, Inc. Vial access adapter and vial combination
AU2003217677A1 (en) * 2002-02-25 2003-09-09 Mitali Dutt Probe-activated medicament injector device
US7086431B2 (en) * 2002-12-09 2006-08-08 D'antonio Consultants International, Inc. Injection cartridge filling apparatus
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
EP1454609B1 (de) * 2003-03-05 2012-10-24 CSL Behring GmbH Transfervorrichtung
EP1454650B1 (de) 2003-03-06 2007-10-10 CSL Behring GmbH Transfervorrichtung, insbesondere für medizinische Fluids
US7261698B2 (en) * 2003-04-24 2007-08-28 Sherwood Services Ag Transfer needle safety apparatus
US7641851B2 (en) 2003-12-23 2010-01-05 Baxter International Inc. Method and apparatus for validation of sterilization process
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
JP4953018B2 (ja) * 2005-03-15 2012-06-13 味の素株式会社 薬剤移送具
ES2608284T3 (es) 2006-05-25 2017-04-07 Bayer Healthcare Llc Dispositivo de reconstitución
ES2351527T3 (es) 2006-05-30 2011-02-07 Intarcia Therapeutics, Inc Modulador de flujo en dos piezas con conducto interno para un sistema osmótico de administración.
NZ574524A (en) 2006-08-09 2011-07-29 Intarcia Therapeutics Inc Piston assembly for positioning lumen of a reservoir for an osmotic delivery having a columnar body and a spring
US8177096B2 (en) * 2007-03-27 2012-05-15 International Packaging Innovations, Llc Bag cooler employing a multi-spike adapter and converter
US8770441B2 (en) 2007-03-27 2014-07-08 International Packaging Innovations, Llc Multiple channel single spike for a liquid dispensing system
EP2157967B1 (de) 2007-04-23 2013-01-16 Intarcia Therapeutics, Inc Suspensionsformulierungen insulinotroper peptide und ihre verwendung
US8241265B2 (en) 2007-08-01 2012-08-14 Hospira, Inc. Medicament admixing system
CA2646261A1 (en) * 2007-12-14 2009-06-14 Tyco Healthcare Group Lp Blood collection device with tube retaining structure
DE102008003105A1 (de) * 2008-01-01 2009-07-02 Lts Lohmann Therapie-Systeme Ag Einweginjektor mit handbetätigbarem Kolben und einem Zweikammersystem
WO2009102467A2 (en) 2008-02-13 2009-08-20 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
DE102008054128A1 (de) * 2008-10-31 2010-06-10 Lts Lohmann Therapie-Systeme Ag Injektor und Zwei-Kammer-System mit abdichtendem Behälteradapter
US8356644B2 (en) * 2009-08-07 2013-01-22 Medtronic Minimed, Inc. Transfer guard systems and methods
LT2462246T (lt) 2009-09-28 2017-11-27 Intarcia Therapeutics, Inc Esminio stacionaraus vaisto tiekimo greitas įgyvendinimas ir (arba) nutraukimas
US8721612B2 (en) 2010-12-17 2014-05-13 Hospira, Inc. System and method for intermixing the contents of two containers
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
WO2012132286A1 (ja) * 2011-03-31 2012-10-04 パナソニック株式会社 薬剤移注針及び薬剤移注方法
EP2763619B1 (de) 2011-10-03 2017-11-22 Hospira, Inc. System und verfahren zum mischen des inhalts von zwei behältern
AU2014205437B2 (en) * 2013-01-10 2018-03-08 International Packaging Innovations, Llc Multiple channel single spike for a liquid dispensing system
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
JP6993235B2 (ja) 2015-06-03 2022-01-13 インターシア セラピューティクス，インコーポレイティド インプラントの設置及び撤去システム
EP3458084B1 (de) 2016-05-16 2020-04-01 Intarcia Therapeutics, Inc Für den glucagonrezeptor selektive polypeptide und verfahren zu deren verwendung
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
ES2646920B1 (es) * 2016-06-15 2018-07-23 Industrias Somec Y Ribas, S.L. Dispositivo dispensador de líquidos
KR20190104039A (ko) 2017-01-03 2019-09-05 인타르시아 세라퓨틱스 인코포레이티드 Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법
US10596591B2 (en) * 2017-01-04 2020-03-24 Red Devil Inc. Material dispensing system and method
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB528471A (en) * 1939-05-08 1940-10-30 Paul Dux Improvements in or relating to ampoules or like devices
US3033202A (en) * 1955-10-07 1962-05-08 Baxter Laboratories Inc Parenteral solution equipment and method of using same
US3857392A (en) * 1969-06-04 1974-12-31 Ims Ltd Intravenous container with dislodgeable septum and dislodging piercer
US3674028A (en) * 1969-06-04 1972-07-04 Ims Ltd Multi-mix
US3858580A (en) * 1969-06-04 1975-01-07 Ims Ltd Intravenous container mixing assembly
US3739779A (en) * 1970-04-28 1973-06-19 Medical Electroscience & Pharm Hypodermic syringe and needle construction
AR205565A1 (es) * 1974-04-29 1976-05-14 Abbott Lab Unidad de almacenamiento y transferencia para un aditivo particularmente aplicable a la transferencia de medicamentos
US3977555A (en) * 1974-05-07 1976-08-31 Pharmaco, Inc. Protective safety cap for medicament vial
US4381776A (en) * 1980-06-20 1983-05-03 Haemonetics Corporation Anticoagulant dispensing apparatus and method of use
US4543101A (en) * 1984-03-28 1985-09-24 Adria Laboratories, Inc. Valve device to aid in reconstituting injectable powders
US4610374A (en) * 1984-10-29 1986-09-09 Dougherty Brothers Company Apparatus for mixing flowable materials in sealed containers
US4834152A (en) * 1986-02-27 1989-05-30 Intelligent Medicine, Inc. Storage receptacle sealing and transfer apparatus
US4865189A (en) * 1988-08-24 1989-09-12 Alcon Laboratories, Inc. Device for storage, mixing, and dispensing of two different fluids

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9107160A1 *

Also Published As

Publication number Publication date
US5358501A (en) 1994-10-25
ES2046039T3 (es) 1994-01-16
ATE95415T1 (de) 1993-10-15
DE69003805D1 (de) 1993-11-11
JPH0659302B2 (ja) 1994-08-10
CA2045408A1 (fr) 1991-05-14
DK0453555T3 (da) 1994-01-31
EP0453555B1 (de) 1993-10-06
JPH04500331A (ja) 1992-01-23
WO1991007160A1 (fr) 1991-05-30
DE69003805T2 (de) 1994-05-19

Similar Documents

Publication Publication Date Title
EP0453555B1 (de) Vorratsbehälter für einen bestandteil einer medikamentenlösung
EP0403626B1 (de) Aufbewahrungs- und umfüllflasche zum aufbewahren von zwei bestandteilen einer heilkräftigen substanz
EP1226077B1 (de) Einsatzbereite verbindungsvorrichtung
EP0462255B1 (de) Aufbewahrungs- und umfüllflasche mit doppelter kammer
EP1694269B1 (de) Kappe für die sichere verpackng einer medizinflasche
EP0717611B1 (de) Spritzenvorrichtung zum mischen von zwei präparaten
EP0684846B1 (de) Vorgefüllte spritze zur bewahrung und abgabe eines sterilen flüssigen arzneimittels
EP0406374B1 (de) Aufbewahrungs- und umfüllflasche zum aufbewahren von zwei bestandteilen einer heilkräftigen substanz
EP0448656B1 (de) Länglicher behälter mit zwei getrennten kammern auf der gleichen längsachse
EP0295265B1 (de) Vorrichtung zum aufbewahren von flüssigen oder von flüssigen und festen substanzen
WO2002032372A1 (fr) Dispositif de connexion entre un recipient et un contenant et ensemble pret a l'emploi comprenant un tel dispositif
WO1999036029A1 (fr) Dispositif de confinement etanche, pour la connexion d'un recipient et d'un moyen de delivrance d'une matiere
WO2002053086A1 (fr) Ampoule pour le conditionnement et le transfert d'un liquide ou d'une poudre a usage medical
FR2717086A1 (fr) Dispositif de seringue pour le mélange de deux composés.
WO1997020536A1 (fr) Dispositif pour la preparation d'une solution medicamenteuse reconstituee a partir de deux composants
EP1034772B1 (de) Vorrichtung zum Übertragen einer in einem Flacon enthaltenen Substanz in einen Beutel der eine Lösung enthält
FR2767514A1 (fr) Flacon melangeur mettant en contact deux composants isoles avant leur prelevement et leur injection a l'aide d'une seringue
WO1998049994A1 (fr) Dispositif de mise en solution d'un produit lyophilise, contenu dans une cartouche a usage unique utilisee dans un dispositif d'injection sans aiguille
FR2746653A3 (fr) Seringue a usage medical
FR2708469A1 (fr) Dispositif de seringue pour le mélange de deux composés.
FR2853830A1 (fr) Capuchon de transfert a moyen d'etancheite
CA2045501A1 (fr) Contenant de forme allongee comportant deux compartiments separes, l'un etant le prolongement de l'autre
FR2715311A1 (fr) Dispositif de seringue pour le mélange de deux composés.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19910622

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

17Q First examination report despatched

Effective date: 19920525

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

REF Corresponds to:

Ref document number: 95415

Country of ref document: AT

Date of ref document: 19931015

Kind code of ref document: T

REF Corresponds to:

Ref document number: 69003805

Country of ref document: DE

Date of ref document: 19931111

ITF It: translation for a ep patent filed

Owner name: DOTT. FRANCO CICOGNA

REG Reference to a national code

Ref country code: CH

Ref legal event code: PUE

Owner name: BECTON DICKINSON FRANCE S.A.

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

GBT Gb: translation of ep patent filed (gb section 77(6)(a)/1977)

Effective date: 19931115

EPTA Lu: last paid annual fee
BECA Be: change of holder's address

Free format text: 931006 S.A. *BECTON DICKINSON FRANCE:11 RUE ARISTIDE BERGES, F-38800 LE PONT-DE-CLAIX

BECH Be: change of holder

Free format text: 931006 S.A. *BECTON DICKINSON FRANCE

REG Reference to a national code

Ref country code: FR

Ref legal event code: TP

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2046039

Country of ref document: ES

Kind code of ref document: T3

REG Reference to a national code

Ref country code: GR

Ref legal event code: FG4A

Free format text: 3009935

Ref country code: DK

Ref legal event code: T3

NLS Nl: assignments of ep-patents

Owner name: BECTON DICKINSON FRANCE S.A. TE LE PONT-DE-CLAIX,

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

ITPR It: changes in ownership of a european patent

Owner name: CESSIONE;BECTON DICKINSON FRANCE S.A.

26N No opposition filed
EAL Se: european patent in force in sweden

Ref document number: 91900240.2

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GR

Payment date: 20051129

Year of fee payment: 16

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070604

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20081125

Year of fee payment: 19

Ref country code: DK

Payment date: 20081125

Year of fee payment: 19

Ref country code: LU

Payment date: 20081204

Year of fee payment: 19

Ref country code: NL

Payment date: 20081124

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20081021

Year of fee payment: 19

Ref country code: ES

Payment date: 20081126

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20081126

Year of fee payment: 19

Ref country code: SE

Payment date: 20081128

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20081117

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20081223

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20081128

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20090128

Year of fee payment: 19

REG Reference to a national code

Ref country code: CH

Ref legal event code: PCAR

Free format text: CABINET ROLAND NITHARDT CONSEILS EN PROPRIETE INDUSTRIELLE S.A.;Y-PARC RUE GALILEE;1400 YVERDON-LES-BAINS (CH)

BERE Be: lapsed

Owner name: S.A. *BECTON DICKINSON FRANCE

Effective date: 20091130

REG Reference to a national code

Ref country code: NL

Ref legal event code: V1

Effective date: 20100601

EUG Se: european patent has lapsed
REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: DK

Ref legal event code: EBP

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20091110

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20100730

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091110

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091130

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091130

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091130

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100601

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100601

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091110

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091110

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20110408

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091110

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091111

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20110328

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091111